Market is declining at a pace of 5-6% per week these days, year According to GuruFocus updates, these Guru stocks have reached their 52-Week Highs:
AutoZone Inc. (AZO, Financial) Reached the 52-Week High of $152.76
The prices of AutoZone Inc. (AZO) shares have recently reached the 52-Week High of $152.76.
Autozone is the nation's leading specialty retailer of automotive parts and accessories primarily focusing on do-it-yourself customers. Each of the company's auto parts store carries an extensive product line for cars vans and light trucks including new and re-manufactured automotive hard parts maintenance items and accessories. Many of the company's domestic auto parts stores also has a commercial sales program which provides commercial credit and prompt delivery of parts and other products to local repair garages dealers and service stations. AutoZone Inc. has a market cap of $8.18 billion; its shares were traded at around $152.76 with a P/E ratio of 13.85 and P/S ratio of 1.25. AutoZone Inc. had an annual average earning growth of 23.1% over the past 10 years. GuruFocus rated AutoZone Inc. 3-star for its business predictability .
On March 3, 2009, Autozone Inc. (AZO) reported net sales of $1.4 billion for its second quarter (12 weeks) ended February 14, 2009, an increase of 8.1% from fiscal second quarter 2008 (12 weeks). Domestic same store sales, or sales for stores open at least one year, increased 6.0% for the quarter. Net income for the quarter increased $9.2 million, or 8.6%, over the same period last year to $115.9 million, while diluted earnings per share increased 21.1% to $2.03 per share from $1.67 per share in the year-ago quarter.
AZO is in the portfolios of Edward Lampert of ESL Investments. The Investment Guru have been buying the company’s shares in 4Q 2008 heavily.
O'Reilly Automotive Inc. ( ORLY) Reached the 52-Week High of $32.14
The prices of O'Reilly Automotive Inc. (ORLY, Financial) shares have recently reached 52-Week High of $32.14 O'Reilly Automotive Inc. is also a specialty retailer and supplier of automotive aftermarket parts, tools, supplies, equipment and accessories to both ``do-it-yourself`` customers and professional mechanics or service technicians. O'Reilly Automotive Inc. has a market cap of $4.49 billion; its shares were traded at around $32.14 with a P/E ratio of 20.22 and P/S ratio of 1.25. O'Reilly Automotive Inc. had an annual average earning growth of 19% over the past 10 years. GuruFocus rated O'Reilly Automotive Inc. 4.5-Star for its business predictability.
On February 18, 2009, Company reported fourth quarter 2008 and annual results. Sales for the fourth quarter ended December 31, 2008, totaled $1.1 billion, up 84% from $604 million for
the same period a year ago. Gross profit for the fourth quarter ended December 31, 2008, increased to $515 million (or 46.2% of sales) from $270 million (or 44.7% of sales) for the same period a year ago, representing an increase of 91%. Net income for the fourth quarter ended December 31, 2008, totaled $42.7 million, up 5.2% from $40.6 million for the same period in 2007. Diluted earnings per common share for the fourth quarter ended December 31, 2008, decreased 8.6% to $0.32 on 135.4 million shares versus $0.35 a year ago on 116.3 million shares.
ORLY is in the portfolios of Chuck Akre of Akre Capital Management, LLC, Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc, PRIMECAP Management, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Recent Trades of O'Reilly Automotive Inc. by Directors and Officers:
Buy: Director Joe C Greene bought 2,033 shares of ORLY stock on 11/21/2008 at the average price of $24.5; the price of the stock has increased by 31.18% since.
Sell: Director Joe C Greene sold 20,000 shares of ORLY stock on 02/27/2009 at the average price of $32.32; the price of the stock has decreased by 0.56% since.
Sell: SVP of Distribution Gregory D Johnson sold 5,000 shares of ORLY stock on 02/26/2009 at the average price of $33.43; the price of the stock has decreased by 3.86% since.
Sell: SVP of Merchandise Michael D Swearengin sold 2,800 shares of ORLY stock on 02/24/2009 at the average price of $33; the price of the stock has decreased by 2.61% since.
Sell: SVP of Store Operations/Sales Jeff M Shaw sold 8,900 shares of ORLY stock on 02/24/2009 at the average price of $33.25; the price of the stock has decreased by 3.34% since.
Family Dollar Stores Inc. (FDO, Financial) Reached the 52-Week High of $30.36
The prices of Family Dollar Stores Inc. (FDO) Reached the 52-Week High of $30.36. Family Dollar Stores Inc. is one of the fastest growing discount store chains in the United States. The merchandising concept responsible for this growth provides consumers with good values in low cost basic merchandise for family and home needs. The merchandise is sold at everyday low prices in a no frills low overhead self-service environment. Most merchandise is priced under $10.00. Stores generally range in size from 6000 to 8000 square feet and most are operated under leases. Family Dollar Stores Inc. has a market cap of $3.84 billion; its shares were traded at around $30.36 with a P/E ratio of 16.05 and P/S ratio of 0.55. The dividend yield of Family Dollar Stores Inc. stocks is 1.82%. Family Dollar Stores Inc. had an annual average earning growth of 9.2% over the past 10 years. GuruFocus rated Family Dollar Stores Inc. 3-Star for its business predictability.
On March 5, 2009, Family Dollar Stores, Inc. (NYSE: FDO) reported that net sales for the second quarter ended February 28, 2009, increased 8.7% to approximately $1.992 billion compared with $1.833 billion for the second quarter ended March 1, 2008. Sales in the quarter were driven by double-digit sales growth of consumable merchandise; sales of apparel were soft. Comparable store sales for the quarter increased 6.4%. The Company had 6,643 stores as of February 28, 2009, including 57 new stores opened during the second quarter.
FDO is in the portfolios of Richard Aster Jr of Meridian Fund.
Recent Trades of Family Dollar Stores Inc. by Directors and Officers:
Sell: Executive Vice President Barry W Sullivan sold 7,123 shares of FDO stock on 02/03/2009 at the average price of $29; the price of the stock has increased by 4.69% since.
Sell: Executive Vice President Charles S Jr Gibson sold 82,666 shares of FDO stock on 02/03/2009 at the average price of $29; the price of the stock has increased by 4.69% since.
Sell: Director Sharon A Decker sold 500 shares of FDO stock on 01/29/2009 at the average price of $28.09; the price of the stock has increased by 8.08% since.
Sell: Senior Vice President Charles M Sowers sold 39,080 shares of FDO stock on 01/08/2009 at the average price of $27.88; the price of the stock has increased by 8.9% since.
Sell: Senior Vice President Janet G Kelley sold 36,449 shares of FDO stock on 01/08/2009 at the average price of $28; the price of the stock has increased by 8.43% since.
Sturm Ruger & Company Inc. (RGR, Financial) Reached the 52-Week High of $10.32
The prices of Sturm Ruger & Company Inc. (RGR) shares have declined to close to the 52-Week High of $10.32, which is % off the 52-week high of $9.42. Sturm Ruger & Company Inc. is owned by Gurus we are tracking. Among them, have added to their positions during the past quarter. reduced their positions. Sturm Ruger & Co. is principally engaged in the design manufacture and sale of firearms and precision metal investment castings. The company is the only U.S. firearms manufacturer which offers products in all four industry categories. The company's firearms consist of single-shot autoloading bolt-action lever action and muzzleloading rifles in a range of hunting calibers; shotguns in three gauges; .22 caliber rimfire autoloading pistols and centerfire autoloading pistols in various calibers; single and double-action and muzzleloading revolvers. Sturm Ruger & Company Inc. has a market cap of $183.3 million; its shares were traded at around $10.32 with a P/E ratio of 21.91 and P/S ratio of 1.01.
Business is good. In 2008, the Company reported net sales of $181.4 million and earnings per share of $0.43, compared to net sales of $156.5 million and earnings per share of $0.46 in 2007.
RGR is in the portfolios of Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc.
CV Therapeutics Inc. (CVTX, Financial) Reached the 52-Week High of $15.69
The prices of CV Therapeutics Inc. (CVTX) shares have declined to Reached the 52-Week High of $15.69.
CV Therapeutics is a biopharmaceutical company engaged in the discoveryand development of new small molecule drugs to treat cardiovascular disease, the leading cause of death in the United States. The company has several research and preclinical development programs designed to bring additional drug candidates into human clinical testing. The company is conducting clinical trials for two of our drug candidates including ranolazine which is in its second Phase III trial. CV Therapeutics Inc. has a market cap of $981.23 million; its shares were traded at around $15.69 with and P/S ratio of 6.35. CV Therapeutics Inc. had an annual average earning growth of 7.8% over the past 5 years.
On February 20, 2009, CV Therapeutics, Inc. (CVTX) reported financial results for the fourth quarter and full year ended December 31, 2008. For the year ended December 31, 2008, the company reported a net loss of $98.5 million, or $1.61 per share, compared to a net loss of $181.0 million, or $3.05 per share, for the year ended December 31, 2007. This $1.44 per share reduction represents a 47 percent improvement in net loss from 2007 to 2008. For the quarter ended December 31, 2008, the company reported a net loss of $37.0 million, or $0.60 per share. This compares to a net loss of $34.1 million, or $0.57 per share, for the same quarter in 2007.
Recent Trades of CV Therapeutics Inc. by Directors and Officers:
Sell: SVP, Drug Discovery & Dev Brent K Blackburn sold 1,500 shares of CVTX stock on 02/06/2009 at the average price of $15.5; the price of the stock has increased by 1.23% since.
Sell: SVP, Drug Discovery & Dev Brent K Blackburn sold 1,500 more shares of CVTX stock on 01/07/2009 at the average price of $9.38; the price of the stock has increased by 67.27% since.
Interwoven Inc. (IWOV, Financial) Reached the 52-Week High of $16.09
The prices of Interwoven Inc. (IWOV) shares have reached the 52-Week High of $16.09.
Interwoven Inc. is a provider of software products and services that help businesses and other organizations manage the information that makes up the content of their web sites. The company has designed the software products to help companies rapidly and efficiently develop maintain and extend large web sites that are essential to their businesses. The principal product TeamSite incorporates widely accepted Internet industry standards and is designed with an open architecture that allows it to support a wide variety of Internet software products. Interwoven Inc. has a market cap of $740.79 million; its shares were traded at around $16.09 with a P/E ratio of 21.72 and P/S ratio of 2.85.
On January 23, 2009, Interwoven announced financial results for the three months and year ended December 31, 2008. Interwoven reported total revenues of $69.8 million for the fourth quarter of 2008, an increase of 11% from total revenues of $62.9 million for the fourth quarter of 2007. Net income for the fourth quarter of 2008, calculated in accordance with generally accepted accounting principles, was $10.7 million, or $0.23 per share, compared to net income of $10.7 million, or $0.23 per share, for the same period in 2007. On a non-GAAP basis, Interwoven reported a net income of $10.8 million for the fourth quarter of 2008, or $0.23 per share, compared to non-GAAP net income of $8.2 million, or $0.18 per share, for the fourth quarter of 2007.
Recent Trades of Interwoven Inc. by Directors and Officers:
Sell: Chief Marketing Officer Benjamin E Jr Kiker sold 59,639 shares of IWOV stock on 03/06/2009 at the average price of $16.09; the price of the stock has decreased by 0% since.
SXC Health Solutions Corp. (SXCI, Financial) Reached the 52-Week High of $20.02
The prices of SXC Health Solutions Corp. (SXCI) shares have reached the 52-Week High of $20.02.
SXC Health Solutions Corp. provides pharmacy benefits management services and healthcare IT solutions to the healthcare benefits management industry. The Company's product offerings and solutions combine a wide range of software applications, application service provider, processing services, and professional services designed for many of the largest organizations in the pharmaceutical supply chain such as Federal, provincial and state, and local governments pharmacy benefit managers, managed care organizations, retail pharmacy chains and other healthcare intermediaries. SXC Health Solutions Corp. has a market cap of $466.37 million; its shares were traded at around $20.02 with a P/E ratio of 30.78 and P/S ratio of 5.01.
On March 5, 2009, SXC Health Solutions Corp. announced its financial results for the three- and twelve-month periods ended on December 31, 2008. Revenue was $862.9 million, compared to $93.2 million in fiscal 2007. GAAP net income increased to $15.1 million, or $0.65 per share (diluted), compared to $13.1 million, or $0.61 per share (diluted), in fiscal 2007.
AutoZone Inc. (AZO, Financial) Reached the 52-Week High of $152.76
The prices of AutoZone Inc. (AZO) shares have recently reached the 52-Week High of $152.76.
Autozone is the nation's leading specialty retailer of automotive parts and accessories primarily focusing on do-it-yourself customers. Each of the company's auto parts store carries an extensive product line for cars vans and light trucks including new and re-manufactured automotive hard parts maintenance items and accessories. Many of the company's domestic auto parts stores also has a commercial sales program which provides commercial credit and prompt delivery of parts and other products to local repair garages dealers and service stations. AutoZone Inc. has a market cap of $8.18 billion; its shares were traded at around $152.76 with a P/E ratio of 13.85 and P/S ratio of 1.25. AutoZone Inc. had an annual average earning growth of 23.1% over the past 10 years. GuruFocus rated AutoZone Inc. 3-star for its business predictability .
On March 3, 2009, Autozone Inc. (AZO) reported net sales of $1.4 billion for its second quarter (12 weeks) ended February 14, 2009, an increase of 8.1% from fiscal second quarter 2008 (12 weeks). Domestic same store sales, or sales for stores open at least one year, increased 6.0% for the quarter. Net income for the quarter increased $9.2 million, or 8.6%, over the same period last year to $115.9 million, while diluted earnings per share increased 21.1% to $2.03 per share from $1.67 per share in the year-ago quarter.
AZO is in the portfolios of Edward Lampert of ESL Investments. The Investment Guru have been buying the company’s shares in 4Q 2008 heavily.
O'Reilly Automotive Inc. ( ORLY) Reached the 52-Week High of $32.14
The prices of O'Reilly Automotive Inc. (ORLY, Financial) shares have recently reached 52-Week High of $32.14 O'Reilly Automotive Inc. is also a specialty retailer and supplier of automotive aftermarket parts, tools, supplies, equipment and accessories to both ``do-it-yourself`` customers and professional mechanics or service technicians. O'Reilly Automotive Inc. has a market cap of $4.49 billion; its shares were traded at around $32.14 with a P/E ratio of 20.22 and P/S ratio of 1.25. O'Reilly Automotive Inc. had an annual average earning growth of 19% over the past 10 years. GuruFocus rated O'Reilly Automotive Inc. 4.5-Star for its business predictability.
On February 18, 2009, Company reported fourth quarter 2008 and annual results. Sales for the fourth quarter ended December 31, 2008, totaled $1.1 billion, up 84% from $604 million for
the same period a year ago. Gross profit for the fourth quarter ended December 31, 2008, increased to $515 million (or 46.2% of sales) from $270 million (or 44.7% of sales) for the same period a year ago, representing an increase of 91%. Net income for the fourth quarter ended December 31, 2008, totaled $42.7 million, up 5.2% from $40.6 million for the same period in 2007. Diluted earnings per common share for the fourth quarter ended December 31, 2008, decreased 8.6% to $0.32 on 135.4 million shares versus $0.35 a year ago on 116.3 million shares.
ORLY is in the portfolios of Chuck Akre of Akre Capital Management, LLC, Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc, PRIMECAP Management, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Recent Trades of O'Reilly Automotive Inc. by Directors and Officers:
Buy: Director Joe C Greene bought 2,033 shares of ORLY stock on 11/21/2008 at the average price of $24.5; the price of the stock has increased by 31.18% since.
Sell: Director Joe C Greene sold 20,000 shares of ORLY stock on 02/27/2009 at the average price of $32.32; the price of the stock has decreased by 0.56% since.
Sell: SVP of Distribution Gregory D Johnson sold 5,000 shares of ORLY stock on 02/26/2009 at the average price of $33.43; the price of the stock has decreased by 3.86% since.
Sell: SVP of Merchandise Michael D Swearengin sold 2,800 shares of ORLY stock on 02/24/2009 at the average price of $33; the price of the stock has decreased by 2.61% since.
Sell: SVP of Store Operations/Sales Jeff M Shaw sold 8,900 shares of ORLY stock on 02/24/2009 at the average price of $33.25; the price of the stock has decreased by 3.34% since.
Family Dollar Stores Inc. (FDO, Financial) Reached the 52-Week High of $30.36
The prices of Family Dollar Stores Inc. (FDO) Reached the 52-Week High of $30.36. Family Dollar Stores Inc. is one of the fastest growing discount store chains in the United States. The merchandising concept responsible for this growth provides consumers with good values in low cost basic merchandise for family and home needs. The merchandise is sold at everyday low prices in a no frills low overhead self-service environment. Most merchandise is priced under $10.00. Stores generally range in size from 6000 to 8000 square feet and most are operated under leases. Family Dollar Stores Inc. has a market cap of $3.84 billion; its shares were traded at around $30.36 with a P/E ratio of 16.05 and P/S ratio of 0.55. The dividend yield of Family Dollar Stores Inc. stocks is 1.82%. Family Dollar Stores Inc. had an annual average earning growth of 9.2% over the past 10 years. GuruFocus rated Family Dollar Stores Inc. 3-Star for its business predictability.
On March 5, 2009, Family Dollar Stores, Inc. (NYSE: FDO) reported that net sales for the second quarter ended February 28, 2009, increased 8.7% to approximately $1.992 billion compared with $1.833 billion for the second quarter ended March 1, 2008. Sales in the quarter were driven by double-digit sales growth of consumable merchandise; sales of apparel were soft. Comparable store sales for the quarter increased 6.4%. The Company had 6,643 stores as of February 28, 2009, including 57 new stores opened during the second quarter.
FDO is in the portfolios of Richard Aster Jr of Meridian Fund.
Recent Trades of Family Dollar Stores Inc. by Directors and Officers:
Sell: Executive Vice President Barry W Sullivan sold 7,123 shares of FDO stock on 02/03/2009 at the average price of $29; the price of the stock has increased by 4.69% since.
Sell: Executive Vice President Charles S Jr Gibson sold 82,666 shares of FDO stock on 02/03/2009 at the average price of $29; the price of the stock has increased by 4.69% since.
Sell: Director Sharon A Decker sold 500 shares of FDO stock on 01/29/2009 at the average price of $28.09; the price of the stock has increased by 8.08% since.
Sell: Senior Vice President Charles M Sowers sold 39,080 shares of FDO stock on 01/08/2009 at the average price of $27.88; the price of the stock has increased by 8.9% since.
Sell: Senior Vice President Janet G Kelley sold 36,449 shares of FDO stock on 01/08/2009 at the average price of $28; the price of the stock has increased by 8.43% since.
Sturm Ruger & Company Inc. (RGR, Financial) Reached the 52-Week High of $10.32
The prices of Sturm Ruger & Company Inc. (RGR) shares have declined to close to the 52-Week High of $10.32, which is % off the 52-week high of $9.42. Sturm Ruger & Company Inc. is owned by Gurus we are tracking. Among them, have added to their positions during the past quarter. reduced their positions. Sturm Ruger & Co. is principally engaged in the design manufacture and sale of firearms and precision metal investment castings. The company is the only U.S. firearms manufacturer which offers products in all four industry categories. The company's firearms consist of single-shot autoloading bolt-action lever action and muzzleloading rifles in a range of hunting calibers; shotguns in three gauges; .22 caliber rimfire autoloading pistols and centerfire autoloading pistols in various calibers; single and double-action and muzzleloading revolvers. Sturm Ruger & Company Inc. has a market cap of $183.3 million; its shares were traded at around $10.32 with a P/E ratio of 21.91 and P/S ratio of 1.01.
Business is good. In 2008, the Company reported net sales of $181.4 million and earnings per share of $0.43, compared to net sales of $156.5 million and earnings per share of $0.46 in 2007.
RGR is in the portfolios of Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc.
CV Therapeutics Inc. (CVTX, Financial) Reached the 52-Week High of $15.69
The prices of CV Therapeutics Inc. (CVTX) shares have declined to Reached the 52-Week High of $15.69.
CV Therapeutics is a biopharmaceutical company engaged in the discoveryand development of new small molecule drugs to treat cardiovascular disease, the leading cause of death in the United States. The company has several research and preclinical development programs designed to bring additional drug candidates into human clinical testing. The company is conducting clinical trials for two of our drug candidates including ranolazine which is in its second Phase III trial. CV Therapeutics Inc. has a market cap of $981.23 million; its shares were traded at around $15.69 with and P/S ratio of 6.35. CV Therapeutics Inc. had an annual average earning growth of 7.8% over the past 5 years.
On February 20, 2009, CV Therapeutics, Inc. (CVTX) reported financial results for the fourth quarter and full year ended December 31, 2008. For the year ended December 31, 2008, the company reported a net loss of $98.5 million, or $1.61 per share, compared to a net loss of $181.0 million, or $3.05 per share, for the year ended December 31, 2007. This $1.44 per share reduction represents a 47 percent improvement in net loss from 2007 to 2008. For the quarter ended December 31, 2008, the company reported a net loss of $37.0 million, or $0.60 per share. This compares to a net loss of $34.1 million, or $0.57 per share, for the same quarter in 2007.
Recent Trades of CV Therapeutics Inc. by Directors and Officers:
Sell: SVP, Drug Discovery & Dev Brent K Blackburn sold 1,500 shares of CVTX stock on 02/06/2009 at the average price of $15.5; the price of the stock has increased by 1.23% since.
Sell: SVP, Drug Discovery & Dev Brent K Blackburn sold 1,500 more shares of CVTX stock on 01/07/2009 at the average price of $9.38; the price of the stock has increased by 67.27% since.
Interwoven Inc. (IWOV, Financial) Reached the 52-Week High of $16.09
The prices of Interwoven Inc. (IWOV) shares have reached the 52-Week High of $16.09.
Interwoven Inc. is a provider of software products and services that help businesses and other organizations manage the information that makes up the content of their web sites. The company has designed the software products to help companies rapidly and efficiently develop maintain and extend large web sites that are essential to their businesses. The principal product TeamSite incorporates widely accepted Internet industry standards and is designed with an open architecture that allows it to support a wide variety of Internet software products. Interwoven Inc. has a market cap of $740.79 million; its shares were traded at around $16.09 with a P/E ratio of 21.72 and P/S ratio of 2.85.
On January 23, 2009, Interwoven announced financial results for the three months and year ended December 31, 2008. Interwoven reported total revenues of $69.8 million for the fourth quarter of 2008, an increase of 11% from total revenues of $62.9 million for the fourth quarter of 2007. Net income for the fourth quarter of 2008, calculated in accordance with generally accepted accounting principles, was $10.7 million, or $0.23 per share, compared to net income of $10.7 million, or $0.23 per share, for the same period in 2007. On a non-GAAP basis, Interwoven reported a net income of $10.8 million for the fourth quarter of 2008, or $0.23 per share, compared to non-GAAP net income of $8.2 million, or $0.18 per share, for the fourth quarter of 2007.
Recent Trades of Interwoven Inc. by Directors and Officers:
Sell: Chief Marketing Officer Benjamin E Jr Kiker sold 59,639 shares of IWOV stock on 03/06/2009 at the average price of $16.09; the price of the stock has decreased by 0% since.
SXC Health Solutions Corp. (SXCI, Financial) Reached the 52-Week High of $20.02
The prices of SXC Health Solutions Corp. (SXCI) shares have reached the 52-Week High of $20.02.
SXC Health Solutions Corp. provides pharmacy benefits management services and healthcare IT solutions to the healthcare benefits management industry. The Company's product offerings and solutions combine a wide range of software applications, application service provider, processing services, and professional services designed for many of the largest organizations in the pharmaceutical supply chain such as Federal, provincial and state, and local governments pharmacy benefit managers, managed care organizations, retail pharmacy chains and other healthcare intermediaries. SXC Health Solutions Corp. has a market cap of $466.37 million; its shares were traded at around $20.02 with a P/E ratio of 30.78 and P/S ratio of 5.01.
On March 5, 2009, SXC Health Solutions Corp. announced its financial results for the three- and twelve-month periods ended on December 31, 2008. Revenue was $862.9 million, compared to $93.2 million in fiscal 2007. GAAP net income increased to $15.1 million, or $0.65 per share (diluted), compared to $13.1 million, or $0.61 per share (diluted), in fiscal 2007.
Become a Premium Member to See This: (Free Trial):
